The hypothesis of a molecular crosstalk between RhoA-ROCK and canonical Wnt pathways might represent a novel molecular mechanism underlying ARVC pathogenesis, and will drive biologists in targeting more specific and less expensive experimental procedures. Here, RHOA is linked to arrhythmogenic right ventricular cardiomyopathy.